Q3 2023 · 13F-HR
Eagle Health Investments LPholdings as filed
Filed 2023-10-27 · accession 0001172661-23-003510
$453.8M
Reported value
23
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G4705A100 | ICLR | ICON PLC | $45.9M | 10.1% | 186,200 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $43.4M | 9.57% | 175,085 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $40.5M | 8.93% | 206,095 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $38.6M | 8.50% | 170,838 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $31.7M | 6.98% | 64,400 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $29.0M | 6.38% | 416,700 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $26.4M | 5.81% | 595,694 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $25.8M | 5.68% | 276,105 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $24.2M | 5.34% | 136,756 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $22.7M | 5.00% | 414,205 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $21.1M | 4.65% | 174,212 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $18.5M | 4.08% | 93,243 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MED INC | $16.3M | 3.58% | 1,494,514 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $16.2M | 3.57% | 117,902 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $12.7M | 2.79% | 43,390 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $11.1M | 2.44% | 337,218 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $6.6M | 1.46% | 267,630 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $6.6M | 1.46% | 1,214,860 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $6.1M | 1.34% | 204,861 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $5.6M | 1.23% | 437,911 | Common | SOLE |
| 730541109 | — | POINT BIOPHARMA GLOBAL INC | $2.0M | 0.45% | 306,142 | Common | SOLE |
| 14171W103 | — | CAREMAX INC | $1.5M | 0.33% | 714,755 | Common | SOLE |
| 36118A100 | — | FUSION PHARMACEUTICALS INC | $1.5M | 0.33% | 579,769 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.